NCT04163406View on ClinicalTrials.gov

The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 21, 2019

Primary Completion Date

November 9, 2020

Study Completion Date

November 9, 2020

Conditions
Anemia, Iron-deficiency
Interventions
DIETARY_SUPPLEMENT

ferrous fumarate

Maize-based porridge fortified with iron (5mg) in form of ferrous fumarate

DIETARY_SUPPLEMENT

ferrous fumarate + GOS

Maize-based porridge fortified with iron (5mg) in form of ferrous fumarate and GOS (3g)

DIETARY_SUPPLEMENT

ferrous fumarate + HMOs

Maize-based porridge fortified with iron (5mg) in form of ferrous fumarate and HMOs (2'-FL (2g) + LNnT(1g))

Trial Locations (1)

Unknown

Msambweni County Referral Hospital, Msambweni

All Listed Sponsors
collaborator

University of Zurich

OTHER

collaborator

Jomo Kenyatta University of Agriculture and Technology

OTHER

collaborator

University Children's Hospital, Zurich

OTHER

lead

Swiss Federal Institute of Technology

OTHER

NCT04163406 - The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants | Biotech Hunter | Biotech Hunter